The government needs to know the true cost of the products it’s purchasing to avoid getting fleeced by unscrupulous suppliers
A soldier being inoculated for anthrax in 2000.
The Pentagon has paid the manufacturer of BioThrax $1.3bn, for a vaccine that an independent report calculates cost only $250m to produce. Photograph: AP/Dave Bowman
An anthrax vaccine of contested quality has paid out over $1bn in profit to a small company in Maryland, despite the fact that the company neither invented the product nor built the production facilities. A new report by Scott Lilly, my colleague at the Centre for American Progress in Washington, has the details: Emergent BioSolutions has billed the Pentagon $1.3bn for BioThrax, which he calculates cost the company roughly just $250m to manufacture. Lilly comments:
“It is hard to imagine that any attempt to reduce federal outlays and shrink the size of the budget deficit will be credible if it does not address the issue of government contracts that pay extraordinary profit margins.”
… BioThrax is considered a “commercial item” – despite the fact that consumers cannot buy it on the open market. Originally developed by military scientists at Fort Detrick, Maryland, in the 1960s, the state of Michigan public health service obtained a licence to produce the vaccine in 1970. At the time, BioThrax was used to help protect mill workers in the textile industry who processed animal hair contaminated with naturally-occurring anthrax.
In 1998, the state of Michigan sold off the facility for an effective cash price of $2.25m – including 28 buildings containing 250,000 square feet of floor space; 59 acres of land and the government licence to manufacture BioThrax.
Today, it has become very clear that BioThrax is both old and very inadequate. A 2002 review of the vaccine by the Institute of Medicine concluded that BioThrax caused swollen arms and muscles, as well as joint pain. According to some campaigners, it may even have resulted in the death of some individuals.
The new owners, which are now a publicly-listed company named Emergent BioSolutions, have three in-house and 24 contract lobbyists. (Lilly explains that, to put Emergent’s lobbying in perspective, one might compare it with Merck, one of the most heavily represented companies in Washington, with close to 40 registered lobbyists. To have the same ratio of lobbyists to revenues as Emergent, Merck would have to hire more than 4,000 additional lobbyists.)
A spate of “accidental fires,” one by one, taking out America’s food supply chain over the past 1.5 years (source of the list via The Gateway Pundit): 1/11/21 A fire that destroyed 75,000-square-foot processing plant in Fayetteville 4/30/21 A fire ignited inside the Smithfield Foods pork processing plant in Monmouth, IL 7/25/21 Three-alarm fire at Kellogg plant in Memphis, 170 emergency…
Yes, this vaccine contains the swine flu antigen used last year and now, plus two other flu antigens. It is very similar to the vaccine banned for children in the UK and Australia, and similar to the vaccine banned last week in Finland and Sweden. But it will “protect the mission” and prevent parents from…
Everybody knows some things are good for health and some things are bad. Yet one rarely learns the magnitude of the positive or negative effect, making it impossible to take the logical approach, which is to balance risks and benefits as we make all sorts of choices. For example, how much benefit will I receive…
Get ready for turbulence ahead. Yesterday American Airlines had almost 300 of its flights canceled, almost 10 percent of its total schedule, far more than ANY other carrier in the United States (Southwest remains second), and another 673 delayed. It is no doubt purely coincidental that I have heard from multiple pilots at American this…
https://childrenshealthdefense.org/defender/chd-legal-action-fda-eua-pfizer-biontech-vaccine-children/ Signed by me and Bobby Kennedy. The first third of the document is below; click on the link for the rest. CHD to Sue FDA for ‘Recklessly Endangering’ Children if Agency Authorizes Pfizer Vaccine for Children 5 to 11 Years Old An advisory committee to the U.S. Food and Drug Administration will meet Tuesday…
How do governments do business with each other? Of course they often share goals, and may benefit jointly from certain actions. But at the most basic level, they offer each other carrots and threaten each other with sticks. Using some combination of these two strategies, the US government obtained the cooperation of 54 governments to…